dualCAR-NK19/70 cell Clinical Trials

1 actively recruiting trial

Also known as: CAR-NK cell

Pipeline

Phase 1/2: 1

Top Sponsors

Aibin Liang，MD，Ph.D.1

Indications

Refractory or Relapsed B-cell Non-Hodgkin Lymphoma1
Cancer1

Other1 trial

Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.